MedTrace Logo

Psychosocial Determinants of Continuing or Discontinuing Infertility Treatment: A Psychological Analysis

NCT00974649 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 315

Last updated 2013-03-29

No results posted yet for this study

Summary

The current study aims to explore and analyse the decision making process of couples in regards to continuing or discontinuing infertility treatment. A longitudinal, prospective cohort design is used which allows the monitoring of patients over a longer period of time. Data will be collected quantitatively (questionnaires) as well as qualitatively (in-depth interviews) to allow for a more specific and in depth experience than can be obtained by using a questionnaire study. Innovative aspects of the study include:

1. exploration of determinants of continuing and discontinuing infertility treatment by using a comprehensive psychological theory (both surface and in-depth)
2. exploration of gender differences in the decision making process in continuing or discontinuing treatment
3. longitudinal and prospective arm of the study will allow to gain insight into the 'process'
4. prediction of continuing/discontinuing treatment based on psychological variables.

Conditions

Interventions

BEHAVIORAL

self-report questionnaire

validated self-report questionnaires on psychosocial determinants

Sponsors & Collaborators

  • Fund for Scientific Research, Flanders, Belgium

    collaborator OTHER

  • University Hospital, Gasthuisberg

    lead OTHER

Principal Investigators

  • Thomas D'Hooghe, M.D., PhD · University Hospital Gasthuisberg, Leuven, Belgium

  • Uschi Van den Broeck, M.A. · University Hospitals Gasthuisberg, Leuven, Belgium

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00974649 on ClinicalTrials.gov